Home » Company » Zymergen's upsized IPO prices at top of expected range, valuing 'biofacturing' company at $3 billion - MarketWatch

By gundri aman Thursday, April 22, 2021 Company

Zymergen's upsized IPO prices at top of expected range, valuing 'biofacturing' company at $3 billion - MarketWatch

Bagikan Berita Ini

0 Response to "Zymergen's upsized IPO prices at top of expected range, valuing 'biofacturing' company at $3 billion - MarketWatch"

Post a Comment

Subscribe to: Post Comments (Atom)